Characterizing initiation, use, and discontinuation of extended-release buprenorphine in a nationally representative United States commercially insured cohort
Jake R. Morgan, Alexander Y. Walley, Sean M. Murphy, Avik Chatterjee, Scott E. Hadland, Joshua A. Barocas, Benjamin P. Linas, Sabrina A. Assoumou
Topics & Concepts
BuprenorphineDiscontinuationNaltrexoneOpioid use disorderMethadoneMedicine(+)-NaloxoneSubstance abuseConfidence intervalCohortMedical prescriptionOpioidEmergency medicineAnesthesiaInternal medicinePsychiatryPharmacologyReceptorOpioid Use Disorder TreatmentHIV, Drug Use, Sexual RiskSubstance Abuse Treatment and Outcomes